The global bioresorbable stents market is expected to reach $ 1.6 billion by 2022 from $ 240.6 million in 2016, at a CAGR of 40.0% during the forecast period of 2018-2023. One of the major driving factors for this market is the expected growth in aging population especially those susceptible to coronary and peripheral artery diseases. Since the incidence of these diseases increases with increasing age, this is an important factor responsible for impacting the growth of this market. Over 6,00,000 thousand implants are manufactured every year and bioresorbable stents are expected to replace conventional metal stents in future. Bioresorbable stents are made of naturally dissolving polymer allowing them dissolve in body after a certain period (approximately two years) once the purpose of widening the clogged artery is served. Hence, avoiding the long term risks of restenosis and thrombosis and limiting the usage of is blood thinning medication.
Increasing focus on patient registration of bioresorbable stents is another important driver of this market. An expected 15 patients are likely to be filed in coming years. Additionally, increasing clinical trials, growing inclination of physicians and patient to encourage implementation of and high traction in minimally invasive therapy market are some of the other key factors responsible to drive the growth of this market.
However, failure of bioresorbable stents in the clinical trials to prove the theoretical advantages which they claim is a major factor that may restraint the growth of this market. Nonetheless, irrespective of this, the perceived benefits of the products yet to be launched are likely to drive the market to over $ 1.5 billion in coming years.
The market for bioresorbable stents is segmented by type of materials (polymer based and metal based), regulatory analysis (FDA, PMA and Ce), rate of absorption (Fast and Slow), type of application (Coronary artery and Peripheral artery) and end-user (Hospitals and Cardiac centers and patients). The metal stents are further classified into Iron, Magnesium, Magnesium rare earth alloys and zinc. Coating technologies, critical technology factors such as cytotoxicity and reduced corrosion rate, and technologies based on polylactide, tyrosine polycarbonate and salicylic acid pertaining to polymer based stents are discussed in details. Additionally, patents are extensively studied to give clarity to our clients for taking critical decisions.
Other key answers the study intends to provide are-
• Why hospitals segment is expected to grow at a faster rate?
• What is the impact of failure of if the clinical trials on the market growth rate?
• Which companies have a competitive edge? Will Abbot be the market leader in 2023?
• Why alloy absorption stent is expected to grow at a higher growth rate?
• Which technology is expected to grow at a faster pace and why?
• Survey on “Customer Preference on bioresorbable stents”.
Some of the major players in this market include Abbott, BIOTRONIK , Arterius Limited, Boston Scientific Corporation, ORBUSNEICH, REVA Medical, Inc., Amaranth Medical, Inc., Elixir Medical Corporation, KYOTO MEDICAL PLANNING Co., Ltd. , Arterial Remodeling Technologies, Boston Scientific Corporation, 480 Biomedical, S3V Vascular Technologies Private Limited and Qualimed.
1 Introduction
1.1 Goal & Objective
1.2 Report Coverage
1.3 Supply Side Data Modelling & Methodology
1.4 Demand Side Data Modelling & Methodology
2 Executive Summary
3 Market Outlook
3.1 Introduction
3.2 Current & Future Outlook
3.3 DROC
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.3.4 Challenges
3.4 Market Entry Matrix
3.5 Market Opportunity Analysis
3.6 Market Regulations
3.7 Pricing Mix
3.8 Key Customers
3.9 Value Chain & Ecosystem
4 Demand Market Analysis
4.1 Bioresorbable stents Market, By Type
4.1.1 Polymer Based
4.1.1.1 Market Size & Forecasts, 2018-2023
4.1.2 Metal Based
4.1.2.1 Market Size & Forecasts, 2018-2023
Iron
Magnesium
Magnesium rare earth alloys
Zinc
Others
5 Bioresorbable stents Market, By Regulatory Analysis
5.1 FDA
Market Size & Forecasts, 2018-2023
5.2 PMA
Market Size & Forecasts, 2018-2023
5.3 Ce
Market Size & Forecasts, 2018-2023
5.4 Others
Market Size & Forecasts, 2018-2023
6 Bioresorbable stents Market, By Rate of Absorption
6.1 Introduction
6.2 Fast
6.2.1 Market Size & Forecasts, 2018-2023
6.3 Slow
6.3.1 Market Size & Forecasts, 2018-2023
7 Bioresorbable stents Market, By Application
7.1 Introduction
7.1 Coronary Artery
7.1.1 Market Size & Forecasts, 2018-2023
7.2 Peripheral Artery
7.2.1 Market Size & Forecasts, 2018-2023
8 Bioresorbable stents Market, By End-User
8.1 Introduction
8.2 Hospitals
8.2.1 Market Size & Forecasts, 2018-2023
8.3 Cardiac Centres
8.3.1 Market Size & Forecasts, 2018-2023
8.4 Patients
8.4.1 Market Size & Forecasts, 2018-2023
9 Bioresorbable stents Market Analysis, By Region
9.1 North America
9.1.1 U.S.
9.1.2 Canada
9.1.3 Mexico
9.2 Europe
9.2.1 Germany
9.2.2 Italy
9.2.3 France
9.2.4 UK
9.2.5 Rest of Europe
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 Australia
9.3.5 Rest of APAC
9.4 Middle East & Africa
9.4.1 Saudi Arabia
9.4.2 UAE
9.4.3 Rest Of MEA
9.5 South America
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Rest of South America
10 Supply Market Analysis
10.1 Strategic Benchmarking
10.1 Market Share Analysis
10.1 Key Players
10.3.1 Abbott
10.3.2 BIOTRONIK
10.3.3 Arterius Limited
10.3.4 Boston Scientific Corporation
10.3.5 ORBUSNEICH
10.3.6 REVA Medical
10.3.7 Amaranth Medical
10.3.8 Elixir Medical Corporation
10.3.9 KYOTO MEDICAL PLANNING Co., Ltd.
10.3.10 Arterial Remodeling Technologies
10.3.11 Boston Scientific Corporation
10.3.12 Boston Scientific Corporation
10.3.13 S3V Vascular Technologies Private Limited
10.3.14 Qualimed & Others
SDMR employs a three way data triangulation approach to arrive at market estimates. We use primary research, secondary research and data triangulation by top down and bottom up approach
Secondary Research:
Our research methodology involves in-depth desk research using various secondary sources. Data is gathered from association/government publications/databases, company websites, press releases, annual reports/presentations/sec filings, technical papers, journals, research papers, magazines, conferences, tradeshows, and blogs.
Key Data Points through secondary research-
Macro-economic data points
Import Export data
Identification of major market trends across various applications
Primary understanding of the industry for both the regions
Competitors analysis for the production capacities, key production sites, competitive landscape
Key customers
Production Capacity
Pricing Scenario
Cost Margin Analysis
Key Data Points through primary research-
Major factors driving the market and its end application markets
Comparative analysis and customer analysis
Regional presence
Collaborations or tie-ups
Annual Production, and sales
Profit Margins
Average Selling Price
Data Triangulation:
Data triangulation is done using top down and bottom approaches. However, to develop accurate market sizing estimations, both the methodologies are used to accurately arrive at the market size. Insert Image
